Laminin 521-enhanced clinical iPSC banking
Since the introduction of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka and his team back in 2006,1,2 there has been a growing interest in harnessing the remarkable potential of these unique cells. In culture, iPSCs can self-renew and differentiate into any cell type derived from all three germ layers: ectoderm, mesoderm, and endoderm. This breakthrough